Turn Therapeutics reported total assets of $16.96M and total liabilities of $16.27M for the quarter ended Jun 2026. This balance sheet covers 8 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current Assets | ||||||||
| Cash & EquivalentsCash & Equiv. | 0.50M | 0.87M | 3.19M | 3.11M | 5.08M | 11.22M | 10.29M | |
| Prepaid Assets | 0.23M | 0.19M | 0.12M | 0.24M | 0.14M | |||
| Current Assets | 1.10M | 3.29M | 5.20M | 11.45M | 10.43M | |||
| Non-Current Assets | ||||||||
| Intangibles | 1.03M | 0.90M | 0.92M | 0.92M | 0.91M | |||
| Goodwill & Intangibles | 1.03M | 0.90M | 0.92M | 0.92M | 0.91M | |||
| Other Non-Current Assets | 0.01M | 0.01M | 5.96M | 6.20M | 5.56M | |||
| Non-Current Assets | 0.95M | 1.00M | 6.97M | 7.19M | 6.53M | |||
| Assets | 2.05M | 4.30M | 12.16M | 18.64M | 16.96M | |||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Notes Payables | 3.03M | 2.77M | 6.11M | |||||
| Payables | 3.03M | 2.77M | 6.11M | |||||
| Accumulated Expenses | 0.67M | 2.26M | 2.93M | 2.32M | 2.61M | |||
| Current Leases | 0.04M | 0.04M | 0.05M | 0.05M | 0.05M | |||
| Current Deferred Revenue | 1.44M | 1.44M | 1.44M | |||||
| Total Current Liabilities | 0.71M | 2.31M | 6.00M | 5.13M | 8.76M | |||
| Non-Current Liabilities | ||||||||
| Non-Current Debt | 5.94M | 6.06M | ||||||
| Non-Current Deffered Revenue | 1.44M | 1.44M | 1.44M | 1.44M | 1.44M | |||
| Operating Leases | 0.08M | 0.05M | 0.03M | 0.02M | 0.01M | |||
| Total Liabilities | 0.41M | 2.23M | -0.82M | -1.77M | 3.79M | 7.48M | 12.53M | 16.27M |
| Shareholder's Equity | ||||||||
| Total Debt | 3.03M | 8.70M | 12.17M | |||||
| Common Equity | -0.41M | -0.18M | 0.82M | 1.77M | 0.50M | 4.69M | 6.12M | 0.69M |
| Liabilities and Shareholders Equity | 2.05M | 4.30M | 12.16M | 18.64M | 16.96M | |||
| Retained Earnings | -19.20M | 23.19M | -22.67M | -22.39M | -23.40M | -29.21M |